Gordon Mills

Has grant

Oregon Health & Science University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

An immunocompetent breast cancer model for exploration of targeted therapy and immunotherapy

Open Date: 2023-10-01

Close Date: 2024-09-30

Grant: Close

An immunocompetent breast cancer model for exploration of targeted therapy and immunotherapy

Open Date: 2022-10-01

Close Date: 2023-09-30

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

S. Stephen Yi

University of Texas at Austin

UNITED STATES

View details

Kangjin Jeong

Oregon Health & Science University

UNITED STATES

View details

Marilyne Labrie

Assistant Professor

Université de Sherbrooke

CANADA

View details

Daniel McGrail

Assistant Professor

Cleveland Clinic

UNITED STATES

View details

James Korkola

Assistant Professor

Oregon Health & Science University

UNITED STATES

View details

Ioannis Zervantonakis

University of Pittsburgh

UNITED STATES

View details

Pepper Schedin

Professor

Oregon Health & Science University

UNITED STATES

View details

Young Hwan Chang

Associate Professor

Oregon Health & Science University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gordon Mills

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

C5aR1 inhibition reprograms tumor associated macrophages and reverses PARP inhibitor resistance in breast cancer

Enhancing anticancer activity of macrophages through rational drug combinations

MIM-CyCIF: masked imaging modeling for enhancing cyclic immunofluorescence (CyCIF) with panel reduction and imputation

Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer

Single-cell trajectory analysis reveals a CD9 positive state to contribute to exit from stem cell-like and embryonic diapause states and transit to drug-resistant states

Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer

Biomolecular Condensation: A New Phase in Cancer Research

A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs

L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary

Mechanical Stress Signaling in Pancreatic Cancer Cells Triggers p38 MAPK- and JNK-Dependent Cytoskeleton Remodeling and Promotes Cell Migration via Rac1/cdc42/Myosin II

Collaborators (8)

S. Stephen Yi

Kangjin Jeong

Marilyne Labrie

Daniel McGrail

James Korkola

Ioannis Zervantonakis

Pepper Schedin

Young Hwan Chang

Make your next move.